Lutetium Lu 177 dotatate

FDA Drug Profile — BEXLUTRY, Lutathera

Lutetium Lu 177 dotatate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including BEXLUTRY, Lutathera. Available dosage form: injection.

Drug details

Generic Name
Lutetium Lu 177 dotatate
Brand Names
BEXLUTRY, Lutathera
Application Number
NDA218525
Sponsor
Curium US LLC
NDC Codes
2
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
LUTETIUM OXODOTREOTIDE LU-177

Indications and Usage

1 INDICATIONS AND USAGE LUTATHERA is indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors. LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.